# Sequencing Treatments for Mothers With ADHD and Their At - Risk Children

> **NCT01816074** · PHASE4 · COMPLETED · sponsor: **Seattle Children's Hospital** · enrollment: 53 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Vyvanse (lisdexamphetamine)
- **BEHAVIORAL:** Behavior Parent Training

## Key facts

- **NCT ID:** NCT01816074
- **Lead sponsor:** Seattle Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2016-10
- **Final completion:** 2017-05-01
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2018-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01816074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01816074, "Sequencing Treatments for Mothers With ADHD and Their At - Risk Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01816074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*